RYPLAZIM J Code: J2998
Injection, plasminogen, human-tvmh, 1 mg
Drug & Product Overview
About RYPLAZIM
Ryplazim is a medication aligned to the HCPCS J Code: J2998 for billing, pricing, and reimbursement purposes in the United States. It is a Hematology drug administered via the intravenous route and manufactured by Kedrion Biopharma.
Manufacturers, reach out to us to add more information.
NDC Code Information
2 NDC packages are crosswalked to J2998. Package detail is available to logged-in subscribers.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| •••••-••••-•• Log in to view | RYPLAZIM | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
| •••••-••••-•• Log in to view | RYPLAZIM | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
RYPLAZIM Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →
RYPLAZIM CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure) |
CMS does not include Ryplazim (J2998) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J2998. Wastage billing guide →
RYPLAZIM Medically Unlikely Edits (MUE)
The most billing units of J2998 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
RYPLAZIM Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Ryplazim billing and coding guide?
Are there any available Ryplazim patient assistance programs?
Where can I find Ryplazim prescribing information?
Where can I find Ryplazim side effect information?
Does billing RYPLAZIM require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to RYPLAZIM.
